PL349137A1 - Use of cholesterol-lowering agent - Google Patents

Use of cholesterol-lowering agent

Info

Publication number
PL349137A1
PL349137A1 PL00349137A PL34913700A PL349137A1 PL 349137 A1 PL349137 A1 PL 349137A1 PL 00349137 A PL00349137 A PL 00349137A PL 34913700 A PL34913700 A PL 34913700A PL 349137 A1 PL349137 A1 PL 349137A1
Authority
PL
Poland
Prior art keywords
cholesterol
lowering agent
lowering
agent
Prior art date
Application number
PL00349137A
Inventor
Ali Raza
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315084&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL349137(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9902590.0A external-priority patent/GB9902590D0/en
Priority claimed from GBGB9921062.7A external-priority patent/GB9921062D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PL349137A1 publication Critical patent/PL349137A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
PL00349137A 1999-02-06 2000-02-01 Use of cholesterol-lowering agent PL349137A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9902590.0A GB9902590D0 (en) 1999-02-06 1999-02-06 Use of cholesterol-lowering agent
GBGB9921062.7A GB9921062D0 (en) 1999-09-08 1999-09-08 Use of cholestrol-lowering agent

Publications (1)

Publication Number Publication Date
PL349137A1 true PL349137A1 (en) 2002-07-01

Family

ID=26315084

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00349137A PL349137A1 (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent

Country Status (22)

Country Link
EP (1) EP1150679A1 (en)
JP (2) JP2002536333A (en)
KR (1) KR100699287B1 (en)
CN (1) CN1347320A (en)
AR (1) AR022462A1 (en)
AU (1) AU769897B2 (en)
BR (1) BR0007991A (en)
CA (1) CA2358641A1 (en)
CZ (1) CZ20012631A3 (en)
EE (1) EE04659B1 (en)
HK (1) HK1040924A1 (en)
HU (1) HUP0105019A3 (en)
ID (1) ID30131A (en)
IL (1) IL144662A0 (en)
IS (1) IS5996A (en)
MY (1) MY136382A (en)
NO (1) NO319827B1 (en)
NZ (1) NZ512681A (en)
PL (1) PL349137A1 (en)
SK (1) SK11112001A3 (en)
TR (1) TR200102236T2 (en)
WO (1) WO2000045819A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
SE0103509D0 (en) * 2001-10-19 2001-10-19 Astrazeneca Ab Rosuvastatin in pre-demented states
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
WO2007142581A1 (en) * 2006-06-07 2007-12-13 Astrazeneca Ab Combination product for the treatment or prevention of dyslipidaemia
US8293721B2 (en) 2007-06-20 2012-10-23 Merck Sharpe & Dohme Corp. CETP inhibitors derived from benzoxazole arylamides
WO2008156715A1 (en) 2007-06-20 2008-12-24 Merck & Co., Inc. Cetp inhibitors derived from benzoxazole arylamides
US8436028B2 (en) 2007-06-20 2013-05-07 Merck Sharp & Dohme Corp CETP inhibitors derived from benzoxazole arylamides
EP2216095A1 (en) * 2009-01-27 2010-08-11 Koninklijke Philips Electronics N.V. Microfluidic device for full blood count

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260446A (en) * 1989-12-22 1993-11-09 Basf Aktiengesellschaft Aminothiazoles
JP2648897B2 (en) * 1991-07-01 1997-09-03 塩野義製薬株式会社 Pyrimidine derivatives

Also Published As

Publication number Publication date
NO20013810D0 (en) 2001-08-03
KR20010089631A (en) 2001-10-06
CA2358641A1 (en) 2000-08-10
AU769897B2 (en) 2004-02-05
AU2305100A (en) 2000-08-25
EP1150679A1 (en) 2001-11-07
JP2011137023A (en) 2011-07-14
HK1040924A1 (en) 2002-06-28
AR022462A1 (en) 2002-09-04
EE200100404A (en) 2002-10-15
NZ512681A (en) 2003-12-19
NO20013810L (en) 2001-10-03
IS5996A (en) 2001-07-10
SK11112001A3 (en) 2002-02-05
BR0007991A (en) 2001-11-06
ID30131A (en) 2001-11-08
HUP0105019A3 (en) 2003-02-28
TR200102236T2 (en) 2001-12-21
WO2000045819A1 (en) 2000-08-10
MY136382A (en) 2008-09-30
CZ20012631A3 (en) 2001-10-17
KR100699287B1 (en) 2007-03-26
JP2002536333A (en) 2002-10-29
CN1347320A (en) 2002-05-01
NO319827B1 (en) 2005-09-19
HUP0105019A2 (en) 2002-05-29
IL144662A0 (en) 2002-05-23
EE04659B1 (en) 2006-08-15

Similar Documents

Publication Publication Date Title
HUP0202477A3 (en) Use of phthalazine derivatives
GB9915414D0 (en) Medical use
PL354623A1 (en) Manufacture of polyglutamate-therapeutic agent conjugates
PL355101A1 (en) Use of h1
GB9900227D0 (en) Use of a composition
IL147891A0 (en) Topical use of anti-muscarnic agents
HK1051325A1 (en) New combination of a betablocker and a cholesterol-lowering agent
PL339848A1 (en) Therapeutic agent against hypephosphataemia
IL144662A0 (en) Use of cholesterol-lowering agent
HK1047241A1 (en) Radioprotecting agent
GB9907965D0 (en) Medical use
HUP0204208A3 (en) Antipruritic agents for external use
EP1218407A4 (en) Uses of kappa-conotoxin pviia
GB0030067D0 (en) Therapeutic agent
PL350963A1 (en) Use of arylalkanoylpyridazines
GB9925379D0 (en) Medical use
AU2001275696A1 (en) Therapeutic agent
GB0018887D0 (en) Compound and their therapeutic use
GB9902590D0 (en) Use of cholesterol-lowering agent
HK1053059A1 (en) New use of imidazotriazinon derivatives
GB9921062D0 (en) Use of cholestrol-lowering agent
GB9906124D0 (en) Therapeutic agent
GB9922825D0 (en) Medical use
GB0024517D0 (en) Use of medicaments
GB9911238D0 (en) Therapeutic use

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)